BeOne Medicines (ONC) Cash from Financing Activities (2015 - 2026)
BeOne Medicines' (ONC) quarterly Cash from Financing Activities came in at -$6.1 million in Q2 2026, down 117.28% year-over-year from $35.0 million in Q2 2025, and down 108.82% quarter-over-quarter from $68.6 million in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Cash from Financing Activities (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Cash from Financing Activities for 12 consecutive years, with -$6.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 117.28% year-over-year to -$6.1 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 11839.71% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 447.66% from the prior year.
- Cash from Financing Activities was -$6.1 million for Q2 2026 at BeOne Medicines, down from $68.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $961.3 million in Q3 2025 and troughed at -$110.4 million in Q4 2022.
- A 5-year average of $95.2 million and a median of $17.8 million in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities plunged 163.86% in 2023 and jumped 7491.79% in 2025, its largest moves.
- Over 5 years, Cash from Financing Activities stood at -$110.4 million in 2022, then jumped by 414.45% to $347.0 million in 2023, then tumbled by 101.3% to -$4.5 million in 2024, then surged by 2243.07% to $96.9 million in 2025, then sank by 106.25% to -$6.1 million in 2026.
- The last three Cash from Financing Activities figures came in at -$6.1 million (Q2 2026), $68.6 million (Q1 2026), and $96.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -426.70 Mn |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | -6.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.05 Mn |
| Mar 31, 2026 | 68.63 Mn |
| Dec 31, 2025 | 96.93 Mn |
| Sep 30, 2025 | 961.27 Mn |
| Jun 30, 2025 | 35.03 Mn |
| Mar 31, 2025 | -33.78 Mn |
| Dec 31, 2024 | -4.52 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Mar 31, 2024 | 162.29 Mn |
| Dec 31, 2023 | 347.05 Mn |
| Sep 30, 2023 | -76.78 Mn |
| Jun 30, 2023 | 166.08 Mn |
| Mar 31, 2023 | -19.87 Mn |
| Dec 31, 2022 | -110.37 Mn |
| Sep 30, 2022 | 120.24 Mn |
| Jun 30, 2022 | -17.58 Mn |
| Mar 31, 2022 | -11.27 Mn |
| Dec 31, 2021 | 3.38 Bn |
| Sep 30, 2021 | 109.21 Mn |
API Access
BeOne Medicines Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();